ERGONEX PHARMA GMBH has a total of 13 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Canada, Germany and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are COLCA GERARD R, NEURIM PHARMA 1991 and TALLIKUT PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | Germany | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Horowski Reinhard | 11 |
#2 | Reiter Rudolf | 11 |
#3 | Ludwig Georg | 8 |
#4 | Bliesath Harald | 7 |
#5 | Tack Johannes | 4 |
#6 | Palla Heinz | 1 |
#7 | Reiter Rudolf Dr | 1 |
#8 | Georg Ludwig | 1 |
#9 | Sigloch Elisabeth | 1 |
#10 | Bliesath Harald Dr | 1 |
Publication | Filing date | Title |
---|---|---|
US2009325997A1 | Pharmaceutical Compositions For The Treatment Of Capillary Arteriopathy | |
DE102006013307B3 | Terguride / proterguride for the treatment of chronic pain | |
DE102005041613A1 | Use of octahydro-indolo-quinoline compound in the preparation of pharmaceutical composition for the treatment and prophylaxis of gastrointestinal and endocardial disease and carcinoid syndrome |